Lifelink Systems

Lifelink Systems develops conversational AI platforms for healthcare that automate patient interactions through mobile digital navigators. The platform uses messaging-based interfaces rather than traditional apps to engage patients in clinical trial education, enrollment, consent, medication information, and care management. Lifelink has demonstrated the ability to conduct 70,000 digital patient conversations in two months, saving 10-15 FTEs worth of time, and has collaborated with Genentech on advanced conversational patient experience platforms. Founded in 2015 and headquartered in San Francisco, the company has raised approximately $16.5M in Series A funding from investors including DigiTx Partners, Primera Capital, and Baleon Capital. Lifelink differentiates itself through its language user interface approach that leverages smartphone messaging, expanding access to targeted genetic testing and supporting inclusive research initiatives with unlimited conversational scale.